![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
||||||||||
|
||||||||||||||||||
![]() |
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
![]() |
Page 2 | Page 3 | Page 4 |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
||||||||||
|
||||||||||||||||||
![]() |
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
![]() |
Page 2 | Page 3 | Page 4 |
Page 4098 Federal Register Vol. 66, No. 11 / Wednesday, January 17, 2001 / Rules and Regulations (i) Unsupervised or “take-home” use. To limit the potential for diversion of opioid agonist treatment medications to the illicit market, opioid agonist treatment medications dispensed to patients for unsupervised use shall be subject to the following requirements. (1)…
Title 42–Public Health CHAPTER I–PUBLIC HEALTH SERVICE, DEPARTMENT OF HEALTH AND HUMAN SERVICES PART 8–CERTIFICATION OF OPIOID TREATMENT PROGRAMS Subpart A–Accreditation Sec. 8.1 Scope. 8.2 Definitions. 8.3 Application for approval as an accreditation body. 8.4 Accreditation body responsibilities. 8.5 Periodic evaluation of accreditation bodies. 8.6 Withdrawal of approval of accreditation bodies. Subpart B–Certification and Treatment Standards 8.11 Opioid treatment program certification. 8.12 Federal…
National Methadone Conference AMTA 2001 A Conference Photo Album Hi Rokki! Proudly wearing her MALTA sweatshirt and NAMA Blue Ribbon Rokki discusses chapter issues with advocates between workshops. Roxanne Baker Chapter Coordinator and Board of Directors, NAMA President NAMA NorCal Carmen Say “Awardee”! Carmen networks with advocates during a break. “Oh it’s nothing!” she says…
Treatment Facility Locator Buprenorphine Physician Locator Center for Substance Abuse Treatment US government search engine to locate all forms of drug treatment. Substance Abuse Mental Health Services Administration (SAMHSA) US government search engine to locate physicians prescribing Buprenorphine. Code of Federal Regulations Federal Register, January 17, 2001 CRF 42 Part 8 in text and…
NAMA Board of Directors Zachary Talbott, MSW, CMA President [email protected] Sharon Larson, RN, MS, CMA Vice Pressident [email protected] Brenda Davis, MSW, CASAC-T, CMA Treasurer [email protected] Megan Marx-Varela, MPA Secretary [email protected] Joycelyn Sue Woods, MA, CARC, CMA Executive Director [email protected] Paul Bowman, CMA, CARC [email protected] Sara E. Gefvert, CRS/CPS, CMA Technology and Communications [email protected] Walter Ginter, CMA Recovery and Peer Services [email protected] Charles Hilger, MSW, LDAC [email protected] Claude Hopkins,…
Methadose Dispensing Emmett Velten, Ph.D. is the Clinical Supervisor at the BAART Methadone Program, San Francisco, CA. Methadone has inspired an immense mythology. Perhaps it is the most extensive mythology surrounding any form of medical or psychological treatment, living or dead. Why has such a mythology developed? This question is important given the deadly stakes…